Navy’s top officer successfully treated for early-stage breast cancer
- Adm. Lisa Franchetti was diagnosed with early-stage breast cancer during a routine mammogram in June.
- She underwent outpatient surgery in July and has since completed additional therapy, now being cancer-free.
- Franchetti advocates for early detection and routine screenings, emphasizing the importance of proactive health measures.
Adm. Lisa Franchetti, the Navy's highest-ranking officer, was diagnosed with stage 1 breast cancer during a routine mammogram in June. Following her diagnosis, she underwent outpatient surgery at Walter Reed National Military Medical Center in July, during which she temporarily transferred her duties to her vice chief of naval operations. The Navy announced that she has since undergone additional therapy and is now cancer-free. Franchetti's case highlights the importance of early detection, as she expressed gratitude for the care she received and emphasized the need for routine screenings. Her diagnosis and treatment come in a year when another senior defense official, Defense Secretary Lloyd Austin, also faced health challenges related to prostate cancer, which he disclosed only after being hospitalized. Franchetti's proactive communication with her superiors, including Defense Secretary Austin and Joint Chiefs Chairman Gen. CQ Brown Jr., contrasts with Austin's delayed notification of his own health issues. This difference in communication may reflect a growing awareness of the importance of transparency regarding health matters within the military. In 2023, President Biden nominated Franchetti to become the first female chief of naval operations, marking a significant milestone in Navy history. Her successful treatment and advocacy for early detection may inspire others in the military and beyond to prioritize their health and seek regular screenings.